FDA approves first treatment for breast cancer with a certain inherited genetic mutation
SILVER SPRING, Md., Jan. 12, 2018 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast cancer that have spread (metastasized) and whose tumors have...
